Overview Clinical Trial to Evaluate the Efficacy and Safety of DWKH Status: Completed Trial end date: 2022-12-16 Target enrollment: Participant gender: Summary Randomized, Double-blind, Parellel, Multicenter, Active-controlled Phase: Phase 3 Details Lead Sponsor: Daewon Pharmaceutical Co., Ltd.